Skip Navigation


European Heart Journal Advance Access originally published online on March 17, 2008
European Heart Journal 2008 29(8):959-960; doi:10.1093/eurheartj/ehn088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/8/959    most recent
ehn088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Squire, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Squire, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again ... ... ...

Iain Squire*

University Hospitals of Leicester, Leicester LE2 7LX, UK

* Corresponding author. Tel: +44 116 252 3125, Fax: +44 116 252 3108, Email: is11@le.ac.uk

This editorial refers to ‘Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients’{dagger} by D.A. Pascual-Figal et al., on page 1011

Footnotes

{dagger} doi:10.1093/eurheartj/ehn023

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 150 words of the full text of this article appear below.

The management of an individual patient should encompass not only consideration of the diagnosis and appropriate treatment, but also assessment of prognosis. This is particularly so in the case of the patient suffering from a condition which may reasonably be expected to have an impact on life expectancy and on quality of life. Chronic heart failure (CHF) certainly meets these criteria, having an impact on prognosis as severe as that of many of the common malignancies1 and on quality of life as severe as other chronic conditions.

Current national and international guidelines, including those of the European Society of Cardiology,2 recognize that assessment of prognosis should be a part of the standard management of the patient with CHF. However, these same guidelines recognize the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients
Domingo A. Pascual-Figal, Maite Domingo, Teresa Casas, Ignasi Gich, Jordi Ordoñez-Llanos, Pedro Martínez, Juan Cinca, Mariano Valdés, James L. Januzzi, and Antoni Bayes-Genis
EHJ 2008 29: 1011-1018. [Abstract] [Full Text]